Ed, for example, why do you persist in keeping the nude photographs with Sofia Loren’s head on the body when you know she objects? You are like the pickpocket at the grocery store who keeps doing it until the store owner speaks to him. But the result is that your infringement is intentional and thus warrants punitive damages. Rather than concocting really stupid theories, why don’t you comply with the federal law?
While the theory a 1st grader wrote the letters may be stupid, because the writer of a short letter would have no reason to involve a young child who then might tell someone (like his mom), the theory you are an intentional copyright violator is rock solid and subject to the available documentary evidence.
On your website, you explain:
FROM WWW.MSNBC.COM:
Sept. 21 — Sophia Loren doesn’t want her good name — or her even better body — being exploited on the Internet. The actress, citing “distress, depression, shame, humiliation, embarrassment and shock,” has slapped 76 Internet companies with a lawsuit, alleging that they’re using her name to lure Web surfers to pornographic sites.
“THE DEFENDANTS ... have purported to display nude or semi-nude pictures of Sophia Loren, and some Defendants … have displayed photographs featuring Ms. Loren’s image without permission from Ms. Loren,” according to the suit, filed in a U.S. district court in Indiana.
The actress, who turned 65 on Monday, is asking for a jury trial. Her lawsuit did not specify damage, but asked for — among other things — “damages and motion for permanent injunction.”
...
Loren issued a statement from her home in Geneva: “I am horrified by the disgusting actions of the offending companies.”
And as for your unqualified scientific discussion of anthrax and spores, here is
an alphabetical list of articles that you haven’t read and that contradict one or more of the points you make.
Abramova, F.A., Grinberg, L.M., Yampolskaya, O.V., and Walker, D.H. 1993.
Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak
of 1979. Proc Natl Acad Sci USA 90(6), 2291Ð2294.
Bales, M.E., Dannenberg, A.L., Brachman, P.S., Kaufmann, A.F., Klatsky, P.C.,
and Ashford, D.A. 2002. Epidemiologic response to anthrax outbreaks: field
investigations, 1950-2001. Emerg. Infect. Dis. 8, 1163Ð1174.
Beall, F. A., Taylor, M. J., and Thorne, C. B. 1962. Rapid lethal effect in rats of
a third component found upon fractionating the toxin of Bacillus anthracis.
J. Bacteriol. 83, 1274Ð1280
Bezdenezhnykh, I.S., and Nikiforov, V.N. 1980. Epidemiologic analysis of anthrax
in Sverdlovsk. Zh Mikrobiol. Epidemiol. Immunobiol. 111Ð113.
Blaustein, R.O., Koehler, T.M., Collier, R.J., and Finkelstein, A. 1989. Anthrax
toxin - channel-forming activity of protective antigen in planar phospholipidbilayers.
Proceedings of the National Academy of Sciences of yhe United
States of America 86(7), 2209Ð2213.
Boutiba-Ben Boubaker, I., and Ben Redjeb, S. 2001. Bacillus anthracis: causative
agent of anthrax. Tunis Med. 79, 642Ð646.
Brachman, P.S., Gold, H., Plotkin, S.A., Fekety, F.R.,Werrin, M., and Ingraham,
N.R. 1962. Field evaluation of a human anthrax vaccine. Am J Public Health
56, 632Ð645.
Bradley, K.A., Mogridge, J., Mourez, M., Collier, R.J., and Young, J.A.
2001. Identification of the cellular receptor for anthrax toxin. Nature Nov
8;414(6860), 225Ð229.
Brossier, F., Guidi-Rontani, C., and Mock, M. 1998. Anthrax toxins.CRSeances
Soc. Biol. Fil. 192, 437Ð444.
Brossier, F., Weber-Levy, M., Mock, M., and Sirard, J.C. 2000. Role of toxin
functional domains in anthrax pathogenesis. Infect. Immun. 68, 1781Ð1786.
Calne, D.B., and Calne, R. 1992. Citation of original research. Lancet 340(8813),
244Ð244.
Cieslak, T.J., and Eitzen, E.M., Jr. 1999. Clinical and epidemiologic principles
of anthrax. Emerg. Infect. Dis. 5, 552Ð555.
Davies, J.C. 1982. A major epidemic of anthrax in Zimbabwe. Cent. Afr. J. Med.
28:291Ð298.
Della Mea, V., and Mizzaro, S. 2004. Measuring retrieval effectiveness: A new
proposal and a first experimental validation. Journal of the American Society
for Information Science and Technology 55(6), 530Ð543.
Dirckx, J.H. Virgil on anthrax. 1981. Am. J. Dermatopathol. 3:191Ð195.
Dixon, T.C., Meselson, M., Guillemin, J., and Hanna, P.C. 1999. Anthrax. New
England Journal of Medicine 341(11): 815Ð826.
Duesbery, N.S., Webb, C.P., Leppla, S.H., Gordon, V.M., Klimpel, K.R., Copeland, T.D., Ahn, N.G., Oskarsson, M.K., Fukasawa, K., Paull, K.D.,
and VandeWoude, G.F. 1998. Proteolytic inactivation of MAP-kinase-kinase
by anthrax lethal factor. Science 280(5364), 734Ð737.
Franz, D.R., Jahrling, P.B., Friedlander, A.M., McClain, D.J., Hoover, D.L.,
Bryne, W.R., Pavlin, J.A., Christopher, G.W., Eitzen, E.M. Jr. 1997. Clinical
recognition and management of patients exposed to biologicalwarfare agents.
JAMA 278(5), 399Ð411.
Friedlander, A.M. 1986. Macrophages are sensitive to anthrax lethal
toxin through an acid- dependent process. J. Biol. Chem. 261:7123Ð
7126.
Friedlander, A.M., Welkos, S.L.L., Pitt, M.L.M., Ezzell, J.W., Worsham, P.L.,
Rose, K.J., Ivens, B.E., Lowe, J.R., Howe, G.B., and Mikesell, P. 1993. Postexposure
Prophylaxis Against Experimental Inhalation Anthrax. Journal of
Infectious Diseases 167, 1239Ð42.
Gardner, R.A. 2001. Anthrax (Bacillus Anthracis). Cambridge Scientific
Abstracts.
Gordon, V.M., Leppla, S.H., and Hewlett, E.L. 1988. Inhibitors of receptormediated
endocytosis block the entry of Bacillus anthracis adenylate cyclase
toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect. Immun.
56(5), 1066Ð1069.
Green, B. D., Battisti, L., Koehler, T. M., Thorne, C. B., and Ivins, B. E. 1985.
Demonstration of a capsule plasmid in bacillus anthracis. Infect Immun. 49(2),
291Ð297.
Hanna P.C., Acosta D., and Collier R.J. 1993. On the Role of macrophages
in Anthrax. Proceedings of the National Academy of Sciences of the United
States of America 90(21), 10198Ð10201.
Harter, S.P., and Hert, C.A. 1997. Evaluation of information retrieval systems:
Approaches, issues, and methods. Annual Review of Information Science and
Technology 32, 3Ð94.
Helgason, E., Okstad, O.A., Caugant, D.A., Johansen, H.A., Fouet, A., Mock,
M., Hegna, I., and Kolsto, A.B. 2000. Bacillus anthracis, Bacillus cereus, and
Bacillus thuringiensisÐone species on the basis of genetic evidence. Appl.
Environ. Microbiol. 66(6), 2627Ð2630.
Hsu,V.P., Lukacs, S.L., Handzel,T., Hayslett, J., Harper, S., Hales,T., Semenova,
V.A., Romero-Steiner, S., Elie, C., Quinn, C.P., Khabbaz, R., Khan, A.S.,
Martin, G., Eisold, J., Schuchat, A., and Hajjeh, R.A. 2002. Opening a Bacillus
anthracis-containing envelope, Capitol Hill, Washington, DC: The public
health response. Emerg. Infect. Dis. 8:1039Ð1043.
180 R. N. KOSTOFF ET AL.
Hugh-Jones, M. 1999. 1996Ð97 Global anthrax report. J. Appl. Microbiol. 87,
189Ð191.
Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Friedlander,
A.M., Hauer, J., McDade, J., Osterholm, M.T., OÕToole, T., Parker,
G., Perl, T.M., Russell, P.K., and Tonat, K. 1999. Anthrax as a biological
weapon: medical and public health management.Working Group on Civilian
Biodefense. JAMA 12;281(18), 1735Ð1745.
Inglesby,T.V., OÕToole,T., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen,
E., Friedlander, A.M., Gerberding, J., Hauer, J., Hughes, J., McDade, J,, Osterholm,
M.T., Parker, G., Perl, T.M., Russell, P.K., and Tonat, K. 2002.Working
Group on Civilian Biodefense. Anthrax as a biological weapon, 2002: updated
recommendations for management. JAMA 287(17), 2236Ð52.
Jedrzejas, M. 2002. Three-dimensional structure and molecular mechanism
of novel enzymes of spore-forming bacteria. Med. Sci. Monit. 8, RA183Ð
90.
Jefferson, T., Demicheli,V., Deeks, J., Graves, P., Pratt, M., and Rivetti, D. 2000.
Vaccines for preventing anthrax. Cochrane Database Syst Rev. CD000975.
Jernigan, D.B., Raghunathan, P.L., Bell, B.P., Brechner, R., Bresnitz, E.A.,
Butler, J.C., Cetron, M., Cohen, M., Doyle, T., Fischer, M., Greene, C.,
Griffith, K.S., Guarner, J., Hadler, J.L., Hayslett, J.A., Meyer, R., Petersen,
L.R., Phillips, M., Pinner, R., Popovic, T., Quinn, C.P., Reefhuis, J., Reissman,
D., Rosenstein, N., Schuchat, A., Shieh, W.J., Siegal, L., Swerdlow, D.L.,
Tenover, F.C., Traeger, M., Ward, J.W., Weisfuse, I., Wiersma, S., Yeskey,
K., Zaki, S., Ashford, D.A., Perkins, B.A., Ostroff, S., Hughes, J., Fleming,
D.,Koplan, J.P., Gerberding, J.L., National Anthrax Epidemiologic Investigation
Team. 2002. Investigation of bioterrorism-related anthrax, United States,
2001: Epidemiologic findings. Emerg. Infect. Dis. 8, 1019Ð1028.
Kagolovsky, Y., and Moehr, J.R. 2004. A new look at information retrieval
evaluation: Proposal for solutions. Journal of Medical Systems 28(1), 103Ð
116.
Kaya, A., Tasyaran, M.A., Erol, S., Ozkurt, Z., and Ozkan, B. 2002. Anthrax in
adults and children: a review of 132 cases in Turkey. Eur. J. Clin. Microbiol.
Infect. Dis. 21, 258Ð261.
Keim, P., Price, L.B., Klevytska, A.M., Smith, K.L., Schupp, J.M., Okinaka, R.,
Jackson, P.J., and Hugh-Jones, M.E. 2000. Multiple-locus variable-number
tandem repeat analysis reveals genetic relationships within Bacillus anthracis.
J. Bacteriol. 182(10), 2928Ð2936.
Khanna, H., and Singh,Y. 2001.War against anthrax. Molecular Medicine 7(12),
795Ð796.
Klimpel, K. R., Molloy, S. S., Thomas, G., and Leppla, S. H. 1992. Anthrax
toxin protective antigen is activated by a cell surface protease with the sequence
specificity and catalytic properties of furin. Proceedings of the National
Academy of Sciences 89, 10277Ð10281.
Klimpel, K.R., Arora, N., and Leppla, S.H. 1994. Anthrax toxin lethal factor
contains a zinc metalloprotease consensus sequence which is required for
lethal toxin activity. Mol. Microbiol. 13(6), 1093Ð100.
Koch, R. 1876. Die aetiologie der Milzbrand-Krankheit, begr¬undet auf die
entwicklungsgeschichte des Bacillus anthracis. Beitr¬age zur Biologie der
Pflanzen 2, 277Ð310.
Kostoff, R. N., Shlesinger, M., and Tshiteya, R. 2004. Nonlinear dynamics
roadmaps using bibliometrics and database tomography. International Journal
of Bifurcation and Chaos 14, 1. 61Ð92.
Leppla, S.H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase
that increases cyclicAMPconcentrations of eukaryotic cells. Proc. Natl. Acad
Sci. USA 79, 3162Ð3166.
Leppla, S.H. 1988. Production and purification of anthrax toxin. Methods Enzymol.
165, 103Ð116.
Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I.,
Shelokov, A., and Yampolskaya, O. 1994. The Sverdlovsk anthrax outbreak
of 1979. Science 266(5188), 1202Ð1208.
Mikesell, P., Ivins, B.E., Ristoph, J.D. and Dreier, T.M. 1983 Infect. Immun. 39,
371Ð376.
Milne, J.C., Furlong, D., Hanna, P.C.,Wall, J.S., and Collier, R.J. 1994. Anthrax
protective antigen forms oligomers during intoxication of mammalian cells.
J. Biol. Chem. 269(32), 20607Ð20612.
Mock M, Fouet A. Anthrax. 2001. Annual Review of Microbiology 55, 647Ð
671.
Morse, S.A., Kellogg, R.B., Perry, S., Meyer, R.F., Bray, D., Nichelson, D.,
and Miller, J.M. 2003. Detecting biothreat agents: the Laboratory Response
Network. ASM News 69, 433Ð437.
Mourez, M., Lacy, D.B., Cunningham, K., Legmann, R., Sellman, B.R.,
Mogridge, J., and Collier, R.J. 2002. 2001: A year of major advances in
anthrax toxin research. Trends Microbiol. 10, 287Ð293.
Oncu, S., Oncu, S., and Sakarya, S. 2003. AnthraxÑan overview. Med Sci
Monit. 9(11) pRA276-83.
Pasteur, L. 1881. De lÕattenuation des virus et de leur retour a la virulence. C R
Acad Sci III. 92, 429Ð435.
Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C.
1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the
LPS/IFN gamma-induced release of NO and TNF alpha. Febs Letters 462(1Ð
2), 199Ð204.
Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C.
2000. Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs:
analysis of the intracellular consequences in macrophages. International
Journal of Medical Microbiology 290(4Ð5), 421Ð427.
Petosa, C., Collier, R.J., Klimpel, K.R., Leppla, S.H., and Liddington, R.C. 1997.
Crystal structure of the anthrax toxin protective antigen. Nature 27;385(6619),
833Ð838.
Pezard, C., Berche, P., and Mock, M. 1991. Contribution of individual toxin
components to virulence of Bacillus anthracis. Infect. Immun. 59(10), 3472Ð
3477.
Read, T.D. Salzberg, S.L., Pop, M., Shumway, M., Umayam, L., Jiang, L.X.,
Holtzapple, E., Busch, J.D., Smith, K.L., Schupp, J.M., Solomon, D., Keim,
P., and Fraser, C.M. 2002. Comparative genome sequencing for discovery of
novel polymorphisms in Bacillus anthracis. Science 296(5575), 2028Ð2033.
Read T.D., Peterson, S.N., Tourasse, N., Baillie, L.W., Paulsen, I.T., Nelson,
K.E., Tettelin, H., Fouts, D.E., Eisen, J.A., Gill, S.R., Holtzapple, E.K.,
Okstad, O.A., Helgason, E., Rilstone, J.,Wu, M., Kolonay, J.F., Beanan, M.J.,
Dodson, R.J., Brinkac, L.M., Gwinn, M., DeBoy, R.T., Madpu, R., Daugherty,
S.C., Durkin, A.S., Haft, D.H., Nelson,W.C., Peterson, J.D., Pop, M., Khouri,
H.M., Radune, D., Benton, J.L., Mahamoud, Y., Jiang, L.X., Hance, I.R.,
Weidman, J.F., Berry, K.J., Plaut, R.D.,Wolf, A.M.,Watkins, K.L., Nierman,
W.C., Hazen, A., Cline, R., Redmond, C., Thwaite, J.E., White, O., Salzberg,
S.L., Thomason, B., Friedlander, A.M., Koehler, T.M., Hanna, P.C., Kolsto,
THE SEMINAL LITERATURE OF ANTHRAX RESEARCH 181
A.B., and Fraser, C.M. 2003. The genome sequence of Bacillus anthracis
Ames and comparison to closely related bacteria. Nature 423(6935), 81Ð
86.
Schmid, G., and Kaufmann, A. 2002. Anthrax in Europe: its epidemiology,
clinical characteristics, and role in bioterrorism. Clin. Microbiol. Infect. 8,
479Ð488.
Shadish, W.R., Tolliver, D., Gray, M., and Sengupta, S.K. 1995. Author judgments
about works they cite - 3 studies from psychology journals. Social
Studies of Science 25(3), 477Ð498.
Singh,Y., Chaudhary,V. K., and Leppla, S. H. 1989.Adeleted variant of Bacillus
anthracis protective antigen is non-toxic and blocks anthrax toxin action in
vivo. J. Biol. Chem. Vol. 264, Issue 32, 19103Ð19107, 11.
Singh, Y., Klimpel, K.R., Goel, S., Swain, P.K., and Leppla, S.H. 1999.
Oligomerization of anthrax toxin protective antigen and binding of lethal
factor during endocytic uptake into mammalian cells. Infection and Immunity
67(4), 1853Ð1859.
Smith, A.J., and Goodman, N.W. 1997. The hypertensive response to intubation.
Do researchers acknowledge previous work? Canadian Journal of Anaesthesia
44(1), 9Ð13.
Smith, H., and Keppie, J. 1954. Observations on experimental anthrax - demonstration
of a specific lethal factor produced in-vivo by bacillus-anthracis. Nature
173(4410), 869Ð870.
Sterne, M. 1939. The use of anthrax vaccines prepared from avirulent (uncapsulated)
variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. Anim. Industry
13, 307Ð312.
Turnbull, P.C. 2002. Introduction: anthrax history, disease and ecology. Curr.
Top. Microbiol. Immunol. 271, 1Ð19.
Turner, A.J., Galvin, J.W., Rubira, R.J., Condron, R.J., and Bradley, T. 1999. Experiences
with vaccination and epidemiological investigations on an anthrax
outbreak in Australia in 1997. J. Appl. Microbiol. 87, 294Ð297.
Vessal, K., Yeganehdoust, J., Dutz, W., and Kohout, E. 1975. Radiological
changes in inhalation anthrax - report of radiological and pathological correlation
in 2 cases. Clinical Radiology 26(4), 471Ð474.
Vitale, G., Bernardi, L., Napolitani, G., Mock, M., and Montecucco, C. 2000.
Susceptibility of mitogen-activated protein kinase kinase family members
to proteolysis by anthrax lethal factor. Biochemical Journal 352, 739Ð745,
Part 3.
Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco,
C. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs
and induces tyrosine/threonine phosphorylation of MAPKs in cultured
macrophages. Biochem. Biophys. Res. Commun. 248(3), 706Ð711.
Welkos, S.L., Lowe, J.R., Eden-McCutchan, F., Vodkin, M., Leppla, S.H., and
Schmidt, J.J. 1988. Sequence and analysis of the DNA encoding protective
antigen of Bacillus anthracis. Gene 69, 287Ð300.
Wesche, J., Elliott, J.L., Falnes, P.O., Olsnes, S., and Collier, R.J. 1998. Characterization
of membrane translocation by anthrax protective antigen. Biochemistry
37(45), 15737Ð15746.
Zhao, J.M., Milne, J.C., and Collier, R.J. 1995. Effect of anthrax toxins lethal
factor on ion channels formed by the protective antigen. Journal of Biological
Chemistry 270(31), 18626Ð18630.